Literature DB >> 20005114

Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus.

Adriana Renzoni1, William L Kelley, Pierre Vaudaux, Ambrose L Cheung, Daniel P Lew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20005114      PMCID： PMC2847831          DOI： 10.1016/j.tim.2009.11.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  15 in total

1.  Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus.

Authors:  N McCallum; G Spehar; M Bischoff; B Berger-Bächi
Journal:  Biochim Biophys Acta       Date:  2006-07-01

2.  DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.

Authors:  Longzhu Cui; Jian-Qi Lian; Hui-Min Neoh; Ethel Reyes; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 3.  The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.

Authors:  Fred C Tenover; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2007-03-28       Impact factor: 9.079

4.  Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin.

Authors:  Fionnuala McAleese; Shang Wei Wu; Krzysztof Sieradzki; Paul Dunman; Ellen Murphy; Steven Projan; Alexander Tomasz
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

Review 5.  Mechanism of action of oritavancin and related glycopeptide antibiotics.

Authors:  Norris E Allen; Thalia I Nicas
Journal:  FEMS Microbiol Rev       Date:  2003-01       Impact factor: 16.408

Review 6.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Authors:  K Hiramatsu
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

7.  Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.

Authors:  Makoto Kuroda; Hiroko Kuroda; Taku Oshima; Fumihiko Takeuchi; Hirotada Mori; Keiichi Hiramatsu
Journal:  Mol Microbiol       Date:  2003-08       Impact factor: 3.501

8.  Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

Authors:  Longzhu Cui; Eiji Tominaga; Hui-Min Neoh; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Authors:  Longzhu Cui; Xiaoxue Ma; Katsuhiro Sato; Keiko Okuma; Fred C Tenover; Elsa M Mamizuka; Curtis G Gemmell; Mi-Na Kim; Marie-Cecile Ploy; N El-Solh; Vivian Ferraz; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.

Authors:  Michael M Mwangi; Shang Wei Wu; Yanjiao Zhou; Krzysztof Sieradzki; Herminia de Lencastre; Paul Richardson; David Bruce; Edward Rubin; Eugene Myers; Eric D Siggia; Alexander Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205
View more
  6 in total

1.  Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.

Authors:  Pierre Vaudaux; Elzbieta Huggler; Louis Bernard; Tristan Ferry; Adriana Renzoni; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

2.  Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance.

Authors:  Elena Galbusera; Adriana Renzoni; Diego O Andrey; Antoinette Monod; Christine Barras; Paolo Tortora; Alessandra Polissi; William L Kelley
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

3.  High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.

Authors:  Ilker Uçkay; Louis Bernard; Marta Buzzi; Stephan Harbarth; Patrice François; Elzbieta Huggler; Tristan Ferry; Jacques Schrenzel; Adriana Renzoni; Pierre Vaudaux; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

4.  The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus.

Authors:  Ambre Jousselin; Adriana Renzoni; Diego O Andrey; Antoinette Monod; Daniel P Lew; William L Kelley
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

5.  Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.

Authors:  P Vaudaux; T Ferry; I Uçkay; P François; J Schrenzel; S Harbarth; A Renzoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-26       Impact factor: 3.267

Review 6.  Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.

Authors:  A M Spagnolo; P Orlando; D Panatto; D Amicizia; F Perdelli; M L Cristina
Journal:  J Prev Med Hyg       Date:  2014-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.